Associate Professor Ziegler is a paediatric oncologist in the Centre for Child Cancer and Blood Disorders at the Sydney Children’s Hospital Network (SCHN) Randwick, as well as a research scientist in the Experimental Therapeutics Program at Children’s Cancer Institute Australia. His current work focuses on the childhood brain cancers, malignant gliomas and medulloblastomas.
As a clinician-scientist, Associate Professor Ziegler’s primary research interest is in the translation of novel targeted therapeutics from the laboratory to the clinic. At SCHN Randwick, he has been instrumental in establishing an early phase clinical trials unit to facilitate such translation.